Dr. Terence Michael Myckatyn, MD

Dr. Myckatyn practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Myckatyn's NPI, 1598781718, was assigned on July 14, 2006. Dr. Myckatyn holds Missouri license 2000173749.

Dr. Myckatyn's primary practice is Washington University School of Medicine, at 1040 N Mason Rd, Saint Louis, MO 63141 in Saint Louis County. The practice phone is (314) 362-4964.

Dr. Myckatyn's primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Myckatyn is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Myckatyn to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Myckatyn practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Myckatyn's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Myckatyn is licensed in Missouri.

CMS data shows 41 Medicare services from Dr. Myckatyn across 2 procedure codes in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $2,930 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Myckatyn in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have cancer, and 55% have high cholesterol. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Myckatyn's median patient age at 54, with 93% women.

In 2024, Dr. Myckatyn wrote 162 Medicare Part D claims for 39 patients. 99% of them were for generic drugs. CMS names the drug for 131 of them, across 6 drugs with 11 or more claims each, at $804 in total drug cost. In 2023, CMS named 144 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Myckatyn for performance year 2024, reported as part of a group. Dr. Myckatyn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of mastectomy by Dr. Myckatyn, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 105 papers to Dr. Myckatyn, published from 2012 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Breast Neoplasms, Breast Implants and Mammaplasty. Dr. Myckatyn has published most often in Plast Reconstr Surg. Dr. Myckatyn's most frequent co-authors are Rajiv P. Parikh, MD, Julie A. Margenthaler, MD and Ali Anwaar Qureshi, MD.

Dmand AI links Dr. Myckatyn to 8 clinical trials, 2 of them phase 1 studies. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Intraductal, Noninfiltrating. Washington University School of Medicine sponsors the most, 8.

CMS Open Payments shows 154 general payments to Dr. Myckatyn from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Rti Surgical, Inc paid the most, $363,507.